Abstract Exhaled nitric oxide (eNO) is elevated in patients with asthma in contrast to healthy subjects, although the variabilityis high.In this study, we tried to reduce the variability of eNO in healthy subjects.We measured eNO using ERS guidelines with a fixed exhalation flow of 250 ml/s in 117 (72 women, 45 men) non-smoking healthy subjects and correlated this to antropometric data and standard lung function measurements.Using a model previously defined by Hyde et al., we selected parameters that were likely to have a high correlation with eNO.ENO waslog-normally distributed.The normalvalues for eNO are significantly (Po0.001) different for men and women: in women meanln eNOlevels (SD) were 1.49 (0.34), in men1.74 (0.41) (back-transformed value 4.43 resp. 5.73 ppb).Using multiple regression analysis, only ln D m,CO , lnTLC and ln sG aw showed a significant positive correlation with ln eNO in men, although only 20% of the variability of eNO could be explained. In women no correlation was observed and only 5% of the variability was explained.The high variability of eNO could only partly be explained in men, which makes the use of reference equations not very helpful.
INTRODUCTION
In the past years many studies were conducted to unravel the role and origin of nitric oxide (NO) in pulmonary diseases (1) . NO is produced by NO-synthase (NOS), of which three isoforms has been identi¢ed (2) . Two of the isoforms are located in the bronchial epithelium, namely neuronal NOS (nNOS) and inducible NOS (iNOS). In the pulmonary vascular system endothelial NOS (eNOS) is expressed in the endothelium, where it produces NO, which acts as a vasodilator. As an increase in exhaled NO (eNO) is seen in asthmatics subjects (3), the research has been focussed on the airway epithelium. In transbronchial biopsies, a great increase in iNOS-expression has been seen in asthmatic subjects, induced by proin£ammatory cytokines (2) . Furthermore, the expression of iNOS correlates with the activity of the disease (4^6), leading to the hope that eNO could be a new measurement tool for disease activity in asthmatic patients. In all studies concerning eNO in healthy and asthmatics subjects, a substantial overlap between the two groups was seen, leading to a reduced discriminative power of the eNO measurement.Therefore, it is important to try to explain the variability of eNO in detail, in order to increase the discriminative power of the measurement. Hyde et al. (7) proposed a model which incorporates the production of NO by the lungs (V NO ), the di¡using capacity for NO (D NO ) that carries NO into the pulmonary capillary blood and the removal by exhalation (V A ). Hyde derived relevant equations and was able to predict steady-state NO levels in subjects.
The above equation shows the relationship between exhaled NO levels (P L ), NO di¡usion (D NO ), production (V NO ) and removal by exhalation (V A ). P B depicts atmospheric pressure, while P H 2 O is the saturated water vapor pressure (47 mmHg or 6.3 kPa). (Derived from Hyde et al. (7)). In this study, we measured exhaled NO levels in healthy subjects to determine the 'normal' levels and attempt to reduce the variability by correcting for covariates, which were derived from the 'Hyde-model'.
METHODS

Model development
Based on the model from Hyde we determined parameters that in£uence eNO levels. The ¢rst parameter is the NO di¡usion capacity (D NO ). Since there is no measuring method available for this parameter, we used the membrane conductance for carbon monoxide (D m,CO ) (8) because it is closely related to D NO . D NO re£ects the membrane conductance like D m,CO and Borland (9) showed that D CO and D NO are related to each other by a factor 4.3.
The production of NO depends on the NOS activity levels, which cannot be measured non-invasively. However, NOS catalysis the conversion of L-arginine into L-citrulline thereby producing NO. As the levels of eNO are in£uenced by the intrapulmonary (10) or intravenously (11) administered L-arginine, serum L-arginine levels could a¡ect eNO.
The ERS criteria (12) for NO measurements request the use of a ¢xed exhalation £ow.This results in a dependency of eNO on TLC: in larger lungs the balance between adding and removing NO shifts. Based on this approach we incorporated total lung capacity in our model. A similar line of reasoning leads to the measurement of the physiological dead space volume (V D ), which can act as a storage barrel for NO. Next to these measurements, standard lung function parameters were measured: peak£ow, MEF 75/50/25 , (forced) vital capacity, FEV 1 , and sG aw .
Subjects
Included were healthy volunteers, not on medication, non-or ex-smokers (quitted more than six months). The exclusion criteria consisted of respiratory tract infection (including rhinitis) in the past 6 weeks, atopic disorders, e.g. seasonal rhinitis, hay fever, eczema and other allergies.
Lung function
Whole body plethysmography was performed on 6200 Autobox DL (SensorMedics Cooperation, Yorba Linda, CA,U.S.A.) with the determination of static and dynamic lung volumes and airway resistance (R aw ).
Carbon monoxide di¡usion capacity, including its subdivisions D m,CO and Q c , was measured on a MasterLab Pro (Erich Jaeger GmbH, Wurzburg, Germany). D m,CO and Q c were determined with the single-breath maneuver technique according to Cotes (13) . Physiological dead space (V d ) measurement was done on an Oxycon Alpha (Erich Jaeger GmbH, Wurzburg, Germany), volume and CO 2 calibrations were performed daily. During tidal breathing CO 2 was continuously measured via a side arm.V d was calculated using the Bohr equation. In healthy subjects the di¡erence between P a CO 2 and P et CO 2 is negligible, so we used P et CO 2 .
Nitric oxide measurements
NO measurements were performed on a chemoluminescence analyzer (type CLD 77 AM, Eco Physics, Zurich, Switzerland). System speci¢cations are detection limit 0.02^0.05 ppb, reaction time 0.1s, and continuous on-line measurement of NO. Sampling £ow was kept constant at 325 ml/min. Expiratory £ow was measured by means of molecular mass gas analysis with ultrasonic transducers,CO 2 was measured via a side arm by infrared sensor (Spiroson Scienti¢c unit, Isler Bioengineering, Dˇrnten, Switzerland).
eNO measurements were performed in all subjects in the morning after an overnight fast, before other tests. After the inhalation of NO-free air toTLC, the subjects exhaled against a positive pressure of 5 cm H 2 O, thus preventing nasal air leakage. Expiratory £ow was kept constant according to ERS recommendations (12) by means of a feedback system with a visual scale representing the on-line mouth pressure, leading to a constant expiratory £ow of 250 ml/s. Each subject repeated the slow exhalation for at least 5 times, with reproducible curves. In all subjects end-tidal NO plateau phase was taken as the eNO value. Before each measurement a zero-point calibration was performed. Twice weekly the NO analyzer was calibrated using zero-NO air, made by room air which was led through an NO capturing ¢lter, and NO in N 2 50 ppm (Linde Ag, Unterschleiheim, Germany).
Blood samples were taken from all subjects in the morning after an overnight fast. Quantitative analysis of arginine was performed on a Biochrom 20 amino acid analyzer with an ion-exchange column (Amersham Pharmacia Biotech, Cambridge, U.K.).
Statistics
Exhaled NO levels are lognormal distributed as described earlier (14^16): a Kolmogorov^Smirnov test showed a signi¢cant departure from the normal distribution (Po0.001). In consequence, all calculations were carried out with the ln-transformed values.The necessity to ln-transform was also present with the other measured (lung function) parameters. Jilma et al. (17) reported that eNO levels are higher in men than in women, therefore we compared levels in men and women by an unpaired ttest.
The parameters listed above and the eNO levels were incorporated into a multiple regression model. Incorporation of a multitude of (irrelevant) parameters can weaken the predictive power of any multiple regression model: we de¢ned useful parameters as those who show high correlation with eNO levels, but with low intercorrelations (18, 19) . To de¢ne the multiple regression model we used forward selection of parameters. Analyses were carried out using SPSS10 (SPSS Inc., Chicago, U.S.A.).The anthropometric data are depicted as mean and standard deviations (SD), a-levels were 0.05. The lung function was expressed as the mean (SD) of the number of standard deviations of the predicted value.
RESULTS
Of 123 subjects who volunteered in this study 6 The mean eNO-levels, the 95% CI of the mean and the 72 SD range are depicted in Table 1 . The unpaired t-test showed highly signi¢cant (Po0.001) di¡erences in eNO levels between men and women. Mean ln-transformed eNO levels were 1.49 (0.34) in women and 1.74 (0.41) ln ppb in men, which corresponds to geometric means of, respectively, 4.43 and 5.73 ppb (Table1): further calculations were done in men and women separately.The correlation matrix between the eNO levels and the others parameters revealed that TLC and weight were signi¢-cantly correlated with eNO ( Table 2 ).The signi¢cant correlation between eNO and weight is however an arti¢cial one because in a correlation matrix for women and men separately, the weight^eNO correlation disappeared: in women the correlation coe⁄cient dropped to 0.049 (P=0.685) and in men to 0.279 (P=0.064).
Within the male and female groups no correlation was present between eNO levels and age (P40.05). When the parameters fromTable 2 were used in a multiple regression analysis none of the parameters could act as powerful predictor of eNO levels in women (Table 3) . Only 5.2% of the variance present in women was explained by the regression analysis. The residual standard deviation in this case was 0.352. In men, 20% of the variance was explained, while the regression analysis showed signi¢cance (P=0.034). The residual standard deviation was 0.366.
Considering the large number of irrelevant parameters, but also knowing the signi¢cant correlation between TLC and eNO levels, we simpli¢ed the model to one containing D m , sG aw and TLC. The outcome shows that the regression becomes stronger in male (P=0.008) The 95% con¢dence intervals depictthe interval of the mean for the ln-transformed eNO values. ( Table 4 ).The residual standard deviation now is 0.367. In females still no signi¢cant regression was found. Regression coe⁄cients for D m,CO , TLC and sG aw in women and men showed were strongly di¡erent in either magnitude or sign. Subsequently, we tried to explain sex di¡erences in eNO levels by incorporating these parameters in a co-variance analysis, which included the parameters mentioned and the interaction between sex and these parameters. The results indicate that the sex di¡erence in eNO levels became non-signi¢cant (P=0.384). The strongest factors were D m,CO (P=0.016), sG aw (P=0.005) and the interaction between TLC and sex (P=0.01). The other factors or interactions were barely not or not signi¢cant. The signi¢cant interaction between sex and TLC is visualized in Fig.1 : it shows a positive correlation between TLC and eNO levels in men and a negative one in women.
DISCUSSION
The reduction of variability of eNO levels by using covariates derived from the Hyde-model (7) appeared to be small. A key factor in this model is the cellular NO production, which is not present in our approach because it can only be measured by means of invasive procedures. When a reliable (and easy) method for the measurement of cellular NO production becomes available we probably can explain more of the eNO level variability.Therefore, we cannot reject or accept the validity of the Hyde-model in explaining eNO levels. In our study serum L-arginine levels were not correlated to eNO levels and will not be a measure for cellular NO production.
Recently, another model for exhaled NO levels was published by Silko¡ et al. (21) . This model is based on the assumption that the alveoli produce NO, leading to a concentration C alv .On expiration the conducting airways add NO to the alveolar amount. The amount added depends on the NO-concentration in the airway wall (C w ), the transfer of NO from the mucosa to the air (D NO ) and the expiratory air£ow. When the £ow is high, not much NO-molecules can be added to a volume of air due to the short contact time. At in¢nite £ows the eNO concentration therefore equals the alveolar concentration. The Silko¡ model o¡ers no new ways to reduce variability because the parameters in that model (C w , C alv and D NO ) are derived by non-linear regression from eNO-levels. Using these parameters to explain eNO variability thus becomes impossible. The coe⁄cients re£ectthe outcome after ln-transformation of the data. The coe⁄cients re£ectthe outcome after ln-transformation of the data.
In our study £ows of approximately 250 ml/s were used, what according to Silko¡ et al. would not re£ect bronchial NO-production, but foremost alveolar NO. In this sense, we like to point at many studies which detected high eNO-levels in asthma (being a disease of the bronchi) using 250 ml/s expiratory £ow (22, 23) .
Reference equations derived from our measurements will have a low predictive power. This implies that large di¡erences are needed to discriminate between normal and abnormal values.Only if the changes in eNO induced by disease are substantial, the wide range of 'normal' values will not overlap with the values in diseased subjects. Simpson and co-workers (24) measured in steroid nave asthmatics mean eNO levels (exhalation £ow rate 100 ml/s) of 9.09 or 17.69 ppb depending whether or not the patients recently had been exposed to indoor allergens, which probably means a considerable overlap between healthy volunteers and asthmatics. It can be calculated that, assuming an overlap of r5% between diseased and healthy eNO-values and based on our measurements, eNO levels in female asthmatics should show a mean (SD) of 2.84 (0.34) and in male asthmatics of 3.34 (0.41) ln ppb to discriminate clearly between healthy and asthmatics (back-transformed value17.0 ppb resp., 28.3 ppb).
Increasing the sample size (assuming that sampling was done in an unbiased way) would not lead to a stronger reduction of eNO levels variability because the standard deviation of a sample is not dependent on its size. The only possible conclusion is that the population standard deviation of eNO levels is relatively large. Compared to other studies in children (15) the range from the +2 SD to the À2 SD value is similar or even smaller.
Baraldi (15) reports such a 4 SD range of 14.5 ppb, while in this study we report 6.65 ppb for women and 10.3 ppb for men. In young adults, this range is reported to be 19.6 ppb (14) . Kharitonov (25) , pooling men and women, reported a 4 SD range of approx. 8.8 ppb, which is very similar to this study. The mean (back-transformed) eNO levels in this study are lower than that of Kharitonov, perhaps due to the fact that apparently Kharitonov did not take account of the lognormal distribution. When one calculates the straightforward mean of such a distribution, the mean is overestimated.
Jilma (17) reported higher eNO levels in men than in women (we con¢rm this observation) and concluded that part of the di¡erences was attributed to body weight. We disagree with this opinion because when weight is a signi¢cant factor, this must be so in males and females, which is not the case.Other factors are responsible for the sex di¡erence, namelyTLC, D m,CO , sG aw and the interaction between sex and TLC. The fact that only these factors are to a great extent responsible for the sex di¡erence rules out major sex di¡erences in the NO synthase levels and/or activity. If a sex di¡erence in the latter would exist, we would not be able to explain the di¡erences using the factors described above. For arguments sake we have to recognize the possibility that NOS activity in men is lower than in women, this would lead to a decrease in sex di¡erences in eNO levels, explained by a reduction of the di¡erences induced byTLC, D m,CO , sG aw .This seems unlikely to us because when we remove the in£uence of TLC, D m,CO and sGaw a di¡er-ence would remain. The remaining di¡erence would be opposite in sign compared to that reported here. The e¡ect of D m,CO on eNO levels is similar in both sexes: the higher the D m,CO is, the lower the eNO levels are. The explanation for this could be quite straightforward: when more NO di¡uses into the bloodstream, less is available for exhalation. The interaction between sex and D m,CO was non-signi¢cant, so we have no arguments that the e¡ect of D m,CO is di¡erent in men and women. A puzzling e¡ect can be noted for theTLC: in men a larger TLC means higher NO levels, but in women lower TLCs are equivalent to higher levels. This phenomenon explains the signi¢cant sex by TLC interaction. In men one could argue that in subjects with a largeTLC the conducting airways are relatively larger, leading to a longer contact time between expired air and bronchial epithelium (with the same £ow rate measured at the mouth). The opposite character in women rules out such an explanation. It is di⁄cult to ¢nd an explanation for these phenomena, but we can rule out several factors. Men and women of all build, height, etc., entered this study in a complete random fashion, so systematic di¡erences due to instrument bias is very unlikely. The correlation we found could be false, which is possible when a few outliers heavily in£uence the regression line or equation. We think that this is not the case: ¢rst of all, the variance in male and female values did not di¡er signi¢cantly as judged by the Levene's test for equality of variances. Secondly, we did check for the presence of strong in£uen-cing points in the regression analysis and this check revealed that no datapoints were present which could 'tilt' the regression line in such a way that theTLC-e¡ect in males is falsely generated.
A correlation between eNO and V d could not be established.The fact that in these healthy subject NO-production in the conducting airways will be low will explain this ¢nding. Moreover, the spread in the V d -values was small, thus o¡ering few possibilities to explain eNOvariability.
In summary, we determined exhaled NO levels in a group of healthy subjects and only found a weak reduction of the variability of these levels, using parameters derived from the model of Hyde or Silko¡. Due to the low variability reduction, the use of reference equations is not very helpful. Men show higher eNO levels than women, which could be explained by the di¡erences in TLC, D m,CO and sG aw and not by weight.
